3 min read FDA Moves to End Compounded Semaglutide and Tirzepatide What It Means for Weight Loss Patients The FDA Just Proposed a Major Change to Compounded Weight Loss Drugs If you've been following the news about weight loss medications, you may have heard that the FDA announced a significant regulatory change on April 30, 2026
In the first one to two weeks after stopping, most patients still experience some appetite suppression and blood sugar regulation
Youll receive personalized guidance on preparing for the treatment, which includes dietary adjustments and lifestyle recommendations to maximize the effectiveness of the medication
For example, as a result of the weight loss and the regulation of sugar, you should also see your HbA1c (blood sugar), blood pressure and cholesterol/triglycerides improve
For example, instead of going from never exercising to signing up for daily 60-minute HIIT classes, start with weekly classes and daily walks and work your way up